"
Team:HZAU-China/Project/Antimicrobial Peptides
From 2013.igem.org
| (6 intermediate revisions not shown) | |||
| Line 38: | Line 38: | ||
ul.menu:after{content:"";display:block;height:0;clear:both;visibility:hidden;} | ul.menu:after{content:"";display:block;height:0;clear:both;visibility:hidden;} | ||
ul.menu, | ul.menu, | ||
| - | ul.menu ul {padding:0;margin:0;list-style:none;position:;width:220px;background:# | + | ul.menu ul {padding:0;margin:0;list-style:none;position:;width:220px;background:#d3f18c;font-family:arial, sans-serif;} |
ul.menu {z-index:100;padding:10px;margin:0 auto;} | ul.menu {z-index:100;padding:10px;margin:0 auto;} | ||
ul.menu ul {z-index:50; | ul.menu ul {z-index:50; | ||
| Line 50: | Line 50: | ||
ul.menu > li {margin-top:2px;font-size:12px;} | ul.menu > li {margin-top:2px;font-size:12px;} | ||
ul.menu > li a {font:normal 16px/29px arial, sans-serif;color:#fff;text-decoration:none;} | ul.menu > li a {font:normal 16px/29px arial, sans-serif;color:#fff;text-decoration:none;} | ||
| - | ul.menu label.open {display:block;background:# | + | ul.menu label.open {display:block;background:#517b1f no-repeat 170px 12px;line-height:30px;position:relative;z- |
| - | + | ||
index:100;font:normal 12px/30px arial, sans-serif;color:#fff;border-radius:10px 10px 0 0;} | index:100;font:normal 12px/30px arial, sans-serif;color:#fff;border-radius:10px 10px 0 0;} | ||
| - | + | ul.menu span {display:block;background:#517b1f;line-height:30px;position:relative;z-index:100;font-size: 16px;padding-left:10px;} | |
| - | ul.menu span {display:block;background:# | + | |
ul.menu label img {position:absolute;left:0;top:0;width:100%;height:30px;} | ul.menu label img {position:absolute;left:0;top:0;width:100%;height:30px;} | ||
ul.menu ul li {margin-top:-30px; | ul.menu ul li {margin-top:-30px; | ||
| Line 63: | Line 61: | ||
transition: 0.5s; | transition: 0.5s; | ||
} | } | ||
| - | ul.menu ul li a {display:block;font:normal 16px/29px arial, sans-serif;color:#000;background:# | + | ul.menu ul li a {display:block;font:normal 16px/29px arial, sans-serif;color:#000;background:#b3e24b;} |
| - | ul.menu ul li a:hover {background:# | + | ul.menu ul li a:hover {background:#d3f18c;} |
ul.menu input {position:absolute;left:-9999px;} | ul.menu input {position:absolute;left:-9999px;} | ||
ul.menu li input:checked + label {background:#069;} | ul.menu li input:checked + label {background:#069;} | ||
| - | ul.menu li input:checked ~ ul {background:# | + | ul.menu li input:checked ~ ul {background:#b3e24b;padding-bottom:10px;} |
ul.menu li input:checked ~ ul li {margin-top:0;} | ul.menu li input:checked ~ ul li {margin-top:0;} | ||
ul.menu label.close {display:block;width:200px;height:30px;background:transparent url("/jscss/demoimg/201208/u-arrow.gif") | ul.menu label.close {display:block;width:200px;height:30px;background:transparent url("/jscss/demoimg/201208/u-arrow.gif") | ||
| Line 77: | Line 75: | ||
ul.menu input.close:checked ~ ul li {margin-top:-30px;} | ul.menu input.close:checked ~ ul li {margin-top:-30px;} | ||
</style> | </style> | ||
| + | |||
<script> | <script> | ||
| Line 105: | Line 104: | ||
<li><a href="https://2013.igem.org/Team:HZAU-China/Project/Bacillus subtilis as Probiotics"><span>Bacillus subtilis as Probiotics</span></a></li> | <li><a href="https://2013.igem.org/Team:HZAU-China/Project/Bacillus subtilis as Probiotics"><span>Bacillus subtilis as Probiotics</span></a></li> | ||
<li><a href="https://2013.igem.org/Team:HZAU-China/Project/Antimicrobial Peptides"><span style="font-size:19px;color=#fff;">Antimicrobial Peptides</span></a></li> | <li><a href="https://2013.igem.org/Team:HZAU-China/Project/Antimicrobial Peptides"><span style="font-size:19px;color=#fff;">Antimicrobial Peptides</span></a></li> | ||
| - | + | <li><a href="https://2013.igem.org/Team:HZAU-China/Project/Methods for rearing flea"><span>Methods for rearing flea</span></a></li> | |
</body> | </body> | ||
</div> | </div> | ||
| Line 115: | Line 114: | ||
<p><br></p> | <p><br></p> | ||
| - | <h3>Antimicrobial peptides( | + | <h3>Antimicrobial peptides (AMPs)</h3> |
| - | <p style="font-size:16px;font-family:arial, sans-serif;"> | + | <p style="font-size:16px;font-family:arial, sans-serif;">As we can see today, numerous pathogens have developed an increasing resistance to commonly used prescribed antibiotics after years of intensive overuse. Hence antimicrobial peptides show their profound advantage over classical antibiotics. AMP is a peptide derived from human or some animals/plants. AMPs can rapidly kill a broad range of microbes including Gram positive and Gram negative, and have additional activities that can affect the quality and effectiveness of the innate immune response. Furthermore, AMPs’ unique action mode makes them less likely to cause resistance in pathogens. They are active over a broad pH range and could survive temperatures up to 100 ◦C. Compared to natural peptides, synthetic AMPs show less toxic side effects, and are, until now, safe to be used in combination with gene therapy. Therefore, we took two AMPs into consideration, Lactoferrin and Human Lysozyme, in our project to kill bacteria. </p> |
<h3>Lactoferrin</h3> | <h3>Lactoferrin</h3> | ||
| - | <p style="font-size:16px;font-family:arial, sans-serif;">Lactoferrin (Lf) is a multifunctional member of the transferrin. Lf is found at the mucosal surface where it functions as a prominent component of the first line of host defense against infection and inflammation. This protein has a broad spectrum of anti-infection and anti-inflammatory function. | + | <p style="font-size:16px;font-family:arial, sans-serif;">Lactoferrin (Lf) is a multifunctional member of the transferrin. Lf is found at the mucosal surface where it functions as a prominent component of the first line of the host defense system against infection and inflammation. This protein has a broad spectrum of anti-infection and anti-inflammatory function. Also, lactoferrin has a broad anti-bacterial range and strong anti-bacterial activity. </p> |
| - | + | ||
<h3>Human Lysozyme</h3> | <h3>Human Lysozyme</h3> | ||
| - | <p style="font-size:16px;font-family:arial, sans-serif;">Human lysozyme (hLZ), the | + | <p style="font-size:16px;font-family:arial, sans-serif;">Human lysozyme (hLZ), the major protein in breast milk, exhibits microbicidal activity to various degrees against several bacterial strains. The HLH peptide and its N-terminal helix (H1) were the most potent bactericidal to bacteria. Evidence shows that HLH peptide and its N-terminal helix (H1) kill bacteria by crossing the outer membrane of Gram-negative bacteria via self-promoted uptake and is able to dissipate the membrane-potential-dependent respiration of Gram-positive bacteria.</p> |
| + | |||
| + | <h3>Reference</h3> | ||
| + | |||
| + | <p style="font-size:16px;font-family:arial, sans-serif;">1. Shin JR, Lim KJ, et al. Display of Multimeric Antimicrobial Peptides on the Escherichia coli Cell Surface and Its Application as Whole-Cell Antibiotics. PLoS ONE, 2013;8(3): e58997. doi:10. 1371/journal.pone.0058997</p> | ||
| + | |||
| + | <p style="font-size:16px;font-family:arial, sans-serif;">2. Lei X, Wanghui X et al. Facile expression and purification of the antimicrobial peptide histatin 1 with a cleavable self-aggregating tag(cSAT) in Escherichia coli. Protein Expression and Purification 2013;88:248-253.</p> | ||
| + | <p style="font-size:16px;font-family:arial, sans-serif;">3. Jang SA, Kim H et al. Mechanism of action and specificity of antimicrobial peptides designed based on buforin IIb. Peptides 2012;34:283-289.</p> | ||
</div> | </div> | ||
</div> | </div> | ||
Latest revision as of 02:46, 28 September 2013
Antimicrobial peptides (AMPs)
As we can see today, numerous pathogens have developed an increasing resistance to commonly used prescribed antibiotics after years of intensive overuse. Hence antimicrobial peptides show their profound advantage over classical antibiotics. AMP is a peptide derived from human or some animals/plants. AMPs can rapidly kill a broad range of microbes including Gram positive and Gram negative, and have additional activities that can affect the quality and effectiveness of the innate immune response. Furthermore, AMPs’ unique action mode makes them less likely to cause resistance in pathogens. They are active over a broad pH range and could survive temperatures up to 100 ◦C. Compared to natural peptides, synthetic AMPs show less toxic side effects, and are, until now, safe to be used in combination with gene therapy. Therefore, we took two AMPs into consideration, Lactoferrin and Human Lysozyme, in our project to kill bacteria.
Lactoferrin
Lactoferrin (Lf) is a multifunctional member of the transferrin. Lf is found at the mucosal surface where it functions as a prominent component of the first line of the host defense system against infection and inflammation. This protein has a broad spectrum of anti-infection and anti-inflammatory function. Also, lactoferrin has a broad anti-bacterial range and strong anti-bacterial activity.
Human Lysozyme
Human lysozyme (hLZ), the major protein in breast milk, exhibits microbicidal activity to various degrees against several bacterial strains. The HLH peptide and its N-terminal helix (H1) were the most potent bactericidal to bacteria. Evidence shows that HLH peptide and its N-terminal helix (H1) kill bacteria by crossing the outer membrane of Gram-negative bacteria via self-promoted uptake and is able to dissipate the membrane-potential-dependent respiration of Gram-positive bacteria.
Reference
1. Shin JR, Lim KJ, et al. Display of Multimeric Antimicrobial Peptides on the Escherichia coli Cell Surface and Its Application as Whole-Cell Antibiotics. PLoS ONE, 2013;8(3): e58997. doi:10. 1371/journal.pone.0058997
2. Lei X, Wanghui X et al. Facile expression and purification of the antimicrobial peptide histatin 1 with a cleavable self-aggregating tag(cSAT) in Escherichia coli. Protein Expression and Purification 2013;88:248-253.
3. Jang SA, Kim H et al. Mechanism of action and specificity of antimicrobial peptides designed based on buforin IIb. Peptides 2012;34:283-289.
